UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.607

Sortiert nach

Duvelisib for the treatment of chronic lymphocytic leukemia

Expert opinion on pharmacotherapy, 2020-07, Vol.21 (11), p.1299-1309

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of adverse events associated with idelalisib treatment: expert panel opinion

Leukemia & lymphoma, 2015-10, Vol.56 (10), p.2779-2786

2015

Link zum Volltext

Verfügbarkeit prüfen

Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway

Bioengineered, 2022-03, Vol.13 (3), p.6794-6806

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting AKT for cancer therapy

Expert opinion on investigational drugs, 2019-11, Vol.28 (11), p.977-988

2019

Link zum Volltext

Verfügbarkeit prüfen

Galangin alleviates rheumatoid arthritis in rats by downregulating the phosphatidylinositol 3-kinase/protein kinase B signaling pathway

Bioengineered, 2022-04, Vol.13 (4), p.11192-11201

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway

Bioengineered, 2021-12, Vol.12 (2), p.11909-11921

2021

Link zum Volltext

Verfügbarkeit prüfen

New phosphatidylinositol 3-kinase inhibitors for cancer

Expert opinion on investigational drugs, 2011-04, Vol.20 (4), p.507-518

2011

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol inhibits basic fibroblast growth factor-induced macrophage colony-stimulating factor synthesis via the PI3-kinase/Akt pathway in osteoblasts

Bioscience, biotechnology, and biochemistry, 2023-11, Vol.87 (12), p.1462-1469

2023

Link zum Volltext

Verfügbarkeit prüfen

Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma

Cancer biology & therapy, 2015-01, Vol.16 (4), p.602-609

2015

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway

Bioengineered, 2021-12, Vol.12 (2), p.12568-12582

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3-kinase/Akt signaling pathway

Bioengineered, 2022-04, Vol.13 (4), p.8382-8395

2022

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of microRNA-145 enhanced docetaxel sensitivity in breast cancer cells via inactivation of protein kinase B gamma-mediated phosphoinositide 3-kinase -protein kinase B pathway

Bioengineered, 2022-04, Vol.13 (4), p.11310-11320

2022

Link zum Volltext

Verfügbarkeit prüfen

LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway

Bioengineered, 2022-04, Vol.13 (4), p.8087-8100

2022

Link zum Volltext

Verfügbarkeit prüfen

Knockdown of lysine (K)-specific demethylase 2B KDM2B inhibits glycolysis and induces autophagy in lung squamous cell carcinoma cells by regulating the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway

Bioengineered, 2021-12, Vol.12 (2), p.12227-12235

2021

Link zum Volltext

Verfügbarkeit prüfen

Staying alive: Metabolic adaptations to quiescence

Cell cycle (Georgetown, Tex.), 2012-05, Vol.11 (9), p.1680-1696

2012

Link zum Volltext

Verfügbarkeit prüfen

Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway

Bioengineered, 2021-01, Vol.12 (1), p.6538-6558

2021

Link zum Volltext

Verfügbarkeit prüfen

Up-regulation of LINC00619 promotes apoptosis and inhibits proliferation, migration and invasion while promoting apoptosis of osteosarcoma cells through inactivation of the HGF-mediated PI3K-Akt signalling pathway

Epigenetics, 2022-02, Vol.17 (2), p.147-160

2022

Link zum Volltext

Verfügbarkeit prüfen

Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway

Pharmaceutical biology, 2021-01, Vol.59 (1), p.1104-1114

2021

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response

Gut microbes, 2021-01, Vol.13 (1), p.1-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

Expert opinion on therapeutic targets, 2013-08, Vol.17 (8), p.921-936

2013

Link zum Volltext

Verfügbarkeit prüfen

Quercetin Regresses Dalton's Lymphoma Growth via Suppression of PI3K/AKT Signaling Leading to Upregulation of p53 and Decrease in Energy Metabolism

Nutrition and cancer, 2015-02, Vol.67 (2), p.354-363

2015

Link zum Volltext

Verfügbarkeit prüfen

Network pharmacology and in vitro experimental verification to explore the mechanism of Sanhua decoction in the treatment of ischaemic stroke

Pharmaceutical biology, 2022-12, Vol.60 (1), p.119-130

2022

Link zum Volltext

Verfügbarkeit prüfen

G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis

Leukemia & lymphoma, 2015-07, Vol.56 (7), p.2170-2181

2015

Link zum Volltext

Verfügbarkeit prüfen

miR-451 suppresses EMT and metastasis in glioma cells

Cell cycle (Georgetown, Tex.), 2021-07, Vol.20 (13), p.1270-1278

2021

Link zum Volltext

Verfügbarkeit prüfen

An update on PTEN modulators - a patent review

Expert opinion on therapeutic patents, 2019-11, Vol.29 (11), p.881-889

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.607

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Complete

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.591)
Mit Volltextzugriff
(1.851)

Publikationsform

Artikel
(2.607)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.607)
Humans
(1.764)
Animals
(1.296)
Cell Biology
(950)
Autophagy
(549)
Cancer
(530)
Pharmacology & Pharmacy
(506)
Signal Transduction
(482)
Mice
(452)
Proteins
(445)
Biology
(424)
Phosphatidylinositol 3-Kinases - Metabolism
(410)
Calcium
(405)
Binding
(396)
Cell
(396)
Bioscience
(394)
Cycle
(394)
Landes
(394)
Organogenesis
(394)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Autophagy
(552)
Cell Cycle
(196)
Cancer Biology & Therapy
(128)
Expert Opinion On Therapeutic Targets
(125)
Leukemia & Lymphoma
(96)
Expert Opinion On Investigational Drugs
(72)
Nutrition And Cancer
(60)
Pharmaceutical Biology
(57)
Bioengineered
(52)
Critical Reviews In Food Science And Nutrition
(46)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Duvelisib for the treatment of chronic lymphocytic leukemia

Management of adverse events associated with idelalisib treatment: expert panel opinion

Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway

Targeting AKT for cancer therapy

Galangin alleviates rheumatoid arthritis in rats by downregulating the phosphatidylinositol 3-kinase/protein kinase B signaling pathway

Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway

New phosphatidylinositol 3-kinase inhibitors for cancer

Resveratrol inhibits basic fibroblast growth factor-induced macrophage colony-stimulating factor synthesis via the PI3-kinase/Akt pathway in osteoblasts

Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma

MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway

MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3-kinase/Akt signaling pathway

Overexpression of microRNA-145 enhanced docetaxel sensitivity in breast cancer cells via inactivation of protein kinase B gamma-mediated phosphoinositide 3-kinase -protein kinase B pathway

LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway

Knockdown of lysine (K)-specific demethylase 2B KDM2B inhibits glycolysis and induces autophagy in lung squamous cell carcinoma cells by regulating the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway

Staying alive: Metabolic adaptations to quiescence

Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway

Up-regulation of LINC00619 promotes apoptosis and inhibits proliferation, migration and invasion while promoting apoptosis of osteosarcoma cells through inactivation of the HGF-mediated PI3K-Akt signalling pathway

Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway

Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response

Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia

Quercetin Regresses Dalton's Lymphoma Growth via Suppression of PI3K/AKT Signaling Leading to Upregulation of p53 and Decrease in Energy Metabolism

Network pharmacology and in vitro experimental verification to explore the mechanism of Sanhua decoction in the treatment of ischaemic stroke

G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis

miR-451 suppresses EMT and metastasis in glioma cells

An update on PTEN modulators - a patent review

Aktive Filter

Suchergebnisse filtern